Overview

A Study of Insulin Peglispro in Healthy Male Japanese Participants

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate how the body processes the study drug known as insulin peglispro and how the study drug affects blood sugar in healthy male Japanese participants. This study will also evaluate safety of the study drug. The study will last up to 46 days for each participant, not including screening.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin, Globin Zinc